NCT00364754 - Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions

Metastatic/Recurrent Breast Cancer

Interventions

DRUG

Tesmilifene (YMB 1002)

Trial Locations (10)

Pharmina, Tbilisi

Chelyabinsk Regional Oncology Dispensary, Chelyabinsk

Blokhin Cancer Research Center, Moscow

Central Clinical Hospital named after Semashko, Moscow

Scientific Research Institute of Oncology named after Petrov, Saint Petersburg

St. Petersburg City Oncology Center, Saint Petersburg

Regional Oncology Dispensary, Yaroslavl

Dnipropetrovsk Municipal Clinical Hospital No.4, Dnipropetrovsk

Kyiv Municipal Oncology Hospital, Kyiv

Lviv Oncology Regional Treatment and Diagnostic Centre, Lviv